DIAZEPAM - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for diazepam and what is the scope of freedom to operate?

Diazepam is the generic ingredient in ten branded drugs marketed by Roche, Chartwell Molecular, Hikma, Aquestive, Bausch, Novel Labs Inc, Abraxis Pharm, Alembic, Beloteca, Dr Reddys, Fresenius Kabi Usa, Hospira, Marsam Pharms Llc, Parenta Pharms, Us Army, Warner Chilcott, Watson Labs, Watson Labs Inc, Pharmacia And Upjohn, Neurelis Inc, Actavis Elizabeth, Aurobindo Pharma Ltd, Barr, Chartwell Rx, Dr Reddys Labs Sa, Duramed Pharms Barr, Endo Operations, Ferndale Labs, Halsey, Ivax Sub Teva Pharms, Martec Usa Llc, Mylan, Nuvo Pharm, Pioneer Pharms, Roxane, Strides Pharma, Teva Pharms, Virtus, Quantum Pharmics, and Waylis Therap, and is included in ninety-one NDAs. There are seven patents protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Diazepam has one hundred and eighteen patent family members in twenty-eight countries.

There are eight drug master file entries for diazepam. Forty-eight suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for DIAZEPAM

International Patents:	118
US Patents:	7
Tradenames:	10
Applicants:	40
NDAs:	91
Drug Master File Entries:	8
Finished Product Suppliers / Packagers:	48
Raw Ingredient (Bulk) Api Vendors:	68
Clinical Trials:	142
Patent Applications:	6,771
Drug Prices:	Drug price trends for DIAZEPAM
Drug Sales Revenues:	Drug sales revenues for DIAZEPAM
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for DIAZEPAM
What excipients (inactive ingredients) are in DIAZEPAM?	DIAZEPAM excipients list
DailyMed Link:	DIAZEPAM at DailyMed

See drug prices for DIAZEPAM

See drug sales revenues for DIAZEPAM

Recent Clinical Trials for DIAZEPAM

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Jordan	Phase 3
Assiut University	N/A
Walter Reed National Military Medical Center	Phase 2

See all DIAZEPAM clinical trials

Generic filers with tentative approvals for DIAZEPAM

Applicant	Application No.	Strength	Dosage Form
⤷ Sign Up	⤷ Sign Up	20MG	FILM;BUCCAL
⤷ Sign Up	⤷ Sign Up	17.5MG	FILM;BUCCAL
⤷ Sign Up	⤷ Sign Up	15MG	FILM;BUCCAL

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for DIAZEPAM

Drug Class	Benzodiazepine

Medical Subject Heading (MeSH) Categories for DIAZEPAM

Adjuvants, Anesthesia
Anesthetics, Intravenous
Anti-Anxiety Agents
Anticonvulsants
Antiemetics
GABA Modulators
Hypnotics and Sedatives
Muscle Relaxants, Central

Anatomical Therapeutic Chemical (ATC) Classes for DIAZEPAM

N05BA	Benzodiazepine derivatives
N05B	ANXIOLYTICS
N05	PSYCHOLEPTICS
N	Nervous system

Paragraph IV (Patent) Challenges for DIAZEPAM

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
VALTOCO	Nasal Spray	diazepam	10 mg/spray	211635	1	2024-02-14
DIASTAT ACUDIAL	Rectal Gel	diazepam	5 mg/mL, 2mL pre-filled syringe	020648	1	2008-12-23
DIASTAT ACUDIAL	Rectal Gel	diazepam	5 mg/mL, 4mL pre- filled syringe	020648	1	2008-12-08
DIASTAT ACUDIAL	Rectal Gel	diazepam	2.5 mg/0.5 mL 5 mg/mL 10 mg/2 mL 15 mg/3 mL 20 mg/4 mL	020648	1	2004-03-23

US Patents and Regulatory Information for DIAZEPAM

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Warner Chilcott	DIAZEPAM	diazepam	TABLET;ORAL	070210-001	Sep 4, 1985		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Aquestive	LIBERVANT	diazepam	FILM;BUCCAL	218623-004	Apr 26, 2024		RX	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Actavis Elizabeth	DIAZEPAM	diazepam	TABLET;ORAL	070781-001	Mar 19, 1986		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for DIAZEPAM

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Waylis Therap	VALIUM	diazepam	TABLET;ORAL	013263-006	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Waylis Therap	VALIUM	diazepam	TABLET;ORAL	013263-004	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Roche	VALRELEASE	diazepam	CAPSULE, EXTENDED RELEASE;ORAL	018179-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for DIAZEPAM

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Portugal	3415139		⤷ Sign Up
Brazil	PI0923403	composições para administração de fármaco	⤷ Sign Up
Mexico	2023002506	FORMULACIONES DE EPINEFRINA INTRANASAL Y METODOS PARA EL TRATAMIENTO DE ENFERMEDADES. (INTRANASAL EPINEPHRINE FORMULATIONS AND METHODS FOR THE TREATMENT OF DISEASE.)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.